Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1953 clinical trials
featured
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

The objective of the RADIANCE II Pivotal study is to demonstrate the effectiveness and safety of the Paradise System in subjects with Stage 2 hypertension on 0-2 medications at the time of consent. Prior to randomization, subjects will be hypertensive in the absence of hypertension medication.

angiography
antihypertensive therapy
hypertensive medication
antihypertensive drugs
hypertension
  • 877 views
  • 10 Jul, 2021
  • 83 locations
featured
CAHtalyst Study: A Research Study for Adults with Classic Congenital Adrenal Hyperplasia (CAH)

The CAHtalyst Study is a clinical research study evaluating an investigational medication for adults 18 years of age and older who have been diagnosed with classic congenital adrenal hyperplasia (CAH). The investigational medication is an oral capsule that will be taken twice daily with breakfast and evening meals. All participants who …

classic congenital adrenal hyperplasia
congenital adrenal hyperplasia
  • 30 views
  • 23 Nov, 2020
  • 1 location
featured
A Study to Assess the Safety of GRF6021 Infusions in Subjects With Parkinson's Disease and Cognitive Impairment

This study will evaluate the safety, tolerability, and potential effects on cognition of GRF6021, a plasma-derived product, administered as an intravenous (IV) infusion, to subjects with Parkinson's disease and cognitive impairment.  

cognitive impairment
dementia
movement disorder
  • 42 views
  • 24 Jan, 2020
  • 1 location
featured
Is fatty liver disease hanging over your head?

If you have fatty liver, you may have some damage as well that is called nonalcoholic steatohepatitis (NASH). If you are interested in resources like lifestyle and weight management counseling, as well as a possible drug treatment the SYNERGY-NASH Study may be an option for you. Talk to your doctor …

  • 72 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 3 Clinical Trial for Patients with Nonalcoholic Steatohepatitis (NASH)

A Phase 3 Clinical Trial for Patients with Nonalcoholic Steatohepatitis (NASH)

  • 588 views
  • 08 Nov, 2020
  • 1 location
featured
A Clinical Trial for Patients with Chronic Pancreatitis

A Clinical Trial for Patients with Chronic Pancreatitis

  • 1316 views
  • 08 Nov, 2020
  • 1 location
featured
Nonalcoholic Fatty Liver / Nonalcoholic steatohepatitis (NASH)

Nonalcoholic Fatty Liver / Nonalcoholic steatohepatitis (NASH)

  • 1488 views
  • 23 Nov, 2020
  • 1 location
featured
Expanded Access with Adjunctive Ganaxolone (GNX) Treatment in Children and Young Adults with Cyclin-dependent Kinase-like 5 (CDKL5) deficiency disorder (CDD)

The primary objective is to provide GNX to patients ≥ 2 years with CDD-related seizures who are refractory to, or intolerant of, standard therapy.

  • 0 views
  • 30 Jun, 2021
  • 2 locations
featured
Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)

Randomized Global Phase 3 Study to Evaluate the Impact on NASH With Fibrosis of Obeticholic Acid Treatment (REGENERATE)

  • 210 views
  • 23 Nov, 2020
  • 1 location
featured
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis

  • 1162 views
  • 25 Mar, 2021
  • 1 location